These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26337959)

  • 21. A novel sphingosine kinase inhibitor induces autophagy in tumor cells.
    Beljanski V; Knaak C; Smith CD
    J Pharmacol Exp Ther; 2010 May; 333(2):454-64. PubMed ID: 20179157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.
    Xue Y; Jiang K; Ou L; Shen M; Yang Y; Lu J; Xu W
    Cell Death Dis; 2022 Jul; 13(7):602. PubMed ID: 35831279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosine kinase 2 inhibitor ABC294640 suppresses neuronal excitability and inhibits multiple endogenously and exogenously expressed voltage-gated ion channels in cultured cells.
    Zhang F; Hu W; Qu L; Cang C
    Channels (Austin); 2020 Dec; 14(1):216-230. PubMed ID: 32615066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells.
    Xu L; Zhang Y; Gao M; Wang G; Fu Y
    Biochem Biophys Res Commun; 2016 Apr; 472(4):662-8. PubMed ID: 26920060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells.
    Chen MB; Yang L; Lu PH; Fu XL; Zhang Y; Zhu YQ; Tian Y
    Biochem Biophys Res Commun; 2015 Aug; 463(4):954-60. PubMed ID: 26071354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT.
    Bandara G; Muñoz-Cano R; Tobío A; Yin Y; Komarow HD; Desai A; Metcalfe DD; Olivera A
    Front Immunol; 2018; 9():631. PubMed ID: 29643855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
    Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
    Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The sphingosine kinase 2 inhibitor ABC294640 inhibits cervical carcinoma cell growth.
    Xu L; Jin L; Yang B; Wang L; Xia Z; Zhang Q; Xu J
    Oncotarget; 2018 Jan; 9(2):2384-2394. PubMed ID: 29416779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Fluorouracil resistance due to sphingosine kinase 2 overexpression in colorectal cancer is associated with myeloid-derived suppressor cell-mediated immunosuppressive effects.
    Li X; Chen Y; Liang Y; Shi W
    BMC Cancer; 2024 Aug; 24(1):983. PubMed ID: 39118083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640.
    Antoon JW; White MD; Meacham WD; Slaughter EM; Muir SE; Elliott S; Rhodes LV; Ashe HB; Wiese TE; Smith CD; Burow ME; Beckman BS
    Endocrinology; 2010 Nov; 151(11):5124-35. PubMed ID: 20861237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sphingosine kinase-2 is overexpressed in large granular lymphocyte leukaemia and promotes survival through Mcl-1.
    LeBlanc FR; Pearson JM; Tan SF; Cheon H; Xing JC; Dunton W; Feith DJ; Loughran TP
    Br J Haematol; 2020 Aug; 190(3):405-417. PubMed ID: 32124438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.
    Narayan S; Ramisetti S; Jaiswal AS; Law BK; Singh-Pillay A; Singh P; Amin S; Sharma AK
    Eur J Med Chem; 2019 Jan; 161():456-467. PubMed ID: 30384048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1/2 inhibitor, on colorectal cancer cell lines in vitro and in vivo.
    Yamaguchi T; Kakefuda R; Tajima N; Sowa Y; Sakai T
    Int J Oncol; 2011 Jul; 39(1):23-31. PubMed ID: 21523318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.
    Britten CD; Garrett-Mayer E; Chin SH; Shirai K; Ogretmen B; Bentz TA; Brisendine A; Anderton K; Cusack SL; Maines LW; Zhuang Y; Smith CD; Thomas MB
    Clin Cancer Res; 2017 Aug; 23(16):4642-4650. PubMed ID: 28420720
    [No Abstract]   [Full Text] [Related]  

  • 35. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
    Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
    Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543.
    Ju T; Gao D; Fang ZY
    Biochem Biophys Res Commun; 2016 Feb; 470(3):728-734. PubMed ID: 26775841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of sphingosine kinase 2 deficiency on the development of TNF-alpha-induced inflammatory arthritis.
    Baker DA; Eudaly J; Smith CD; Obeid LM; Gilkeson GS
    Rheumatol Int; 2013 Oct; 33(10):2677-81. PubMed ID: 23011090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of sphingosine kinase-2 ablates androgen resistant prostate cancer proliferation and survival.
    Gestaut MM; Antoon JW; Burow ME; Beckman BS
    Pharmacol Rep; 2014 Feb; 66(1):174-8. PubMed ID: 24905325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer.
    Antoon JW; White MD; Driver JL; Burow ME; Beckman BS
    Exp Biol Med (Maywood); 2012 Jul; 237(7):832-44. PubMed ID: 22859737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Icaritin activates JNK-dependent mPTP necrosis pathway in colorectal cancer cells.
    Zhou C; Chen Z; Lu X; Wu H; Yang Q; Xu D
    Tumour Biol; 2016 Mar; 37(3):3135-44. PubMed ID: 26427664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.